Elizabeth (Liz) Porterfield cared for her son who had Huntington’s Disease. Liz recently retired from her role as Head, Strategic Planning and Clinical Priorities, with the Scottish Government Health & Social Care Directorates. Liz led the development of several clinical strategies including the National Clinical Strategy, the Cancer Strategy and the Scottish Rare Disease Plan, “It’s Not Rare to have a Rare Disease”. She was a member of the implementation group and of the UK Rare Disease Forum. She was the Government sponsor of Scotland’s National Services Division which commissions all national (including across UK) specialist and screening services, such as the Scottish Molecular and Cytogenetics Consortium and the Molecular Pathology Consortium. She was responsible for putting in place the first ever cancer genetics services for breast, colorectal and ovarian cancer. Elizabeth contributed to the establishment of the Innovative Healthcare Delivery Programme (IHDP) based at the Farr Institute in Edinburgh and the Scottish Genomes Partnership.